Adverse events116

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 116

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Activated partial thromboplastin time prolonged	Investigations	Nivolumab 3mg/kg IV Every 2 Weeks	2	32
other	Activated partial thromboplastin time prolonged	Investigations	Stereotactic Body Radiotherapy & Nivolumab	0	33
other	Alanine aminotransferase increased	Investigations	Nivolumab 3mg/kg IV Every 2 Weeks	2	32
other	Alanine aminotransferase increased	Investigations	Stereotactic Body Radiotherapy & Nivolumab	3	33
other	Alkaline phosphatase increased	Investigations	Nivolumab 3mg/kg IV Every 2 Weeks	4	32
other	Alkaline phosphatase increased	Investigations	Stereotactic Body Radiotherapy & Nivolumab	6	33
other	Anemia	Blood and lymphatic system disorders	Nivolumab 3mg/kg IV Every 2 Weeks	16	32
other	Anemia	Blood and lymphatic system disorders	Stereotactic Body Radiotherapy & Nivolumab	18	33
other	Aspartate aminotransferase increased	Investigations	Nivolumab 3mg/kg IV Every 2 Weeks	3	32
other	Aspartate aminotransferase increased	Investigations	Stereotactic Body Radiotherapy & Nivolumab	5	33
other	Blood bilirubin increased	Investigations	Nivolumab 3mg/kg IV Every 2 Weeks	4	32
other	Blood bilirubin increased	Investigations	Stereotactic Body Radiotherapy & Nivolumab	2	33
other	Creatinine increased	Investigations	Nivolumab 3mg/kg IV Every 2 Weeks	2	32
other	Creatinine increased	Investigations	Stereotactic Body Radiotherapy & Nivolumab	3	33
other	Hypercalcemia	Metabolism and nutrition disorders	Nivolumab 3mg/kg IV Every 2 Weeks	1	32
other	Hypercalcemia	Metabolism and nutrition disorders	Stereotactic Body Radiotherapy & Nivolumab	3	33
other	Hyperglycemia	Metabolism and nutrition disorders	Nivolumab 3mg/kg IV Every 2 Weeks	14	32
other	Hyperglycemia	Metabolism and nutrition disorders	Stereotactic Body Radiotherapy & Nivolumab	12	33
other	Hyperkalemia	Metabolism and nutrition disorders	Nivolumab 3mg/kg IV Every 2 Weeks	2	32
other	Hyperkalemia	Metabolism and nutrition disorders	Stereotactic Body Radiotherapy & Nivolumab	1	33

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02684253/events

API reference For AI assistants

Adverse events116

Sources 3

Read this list from software.